Omeros (OMER) Tops Q1 EPS by 12c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. RNG
2. DECK
3. WDC
4. BMY
5. BYD
6. SPOT
7. WCN
8. TSCO
9. BE
10. SPY

Go back to Omeros (OMER) Tops Q1 EPS by 12c

Omeros Corporation Reports First Quarter 2015 Financial Results

May 11, 2015 4:07 PM EDT

SEATTLE, May 11, 2015 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER), a biopharmaceutical company committed to discovering, developing and commercializing both small-molecule and protein therapeutics for large-market as well as orphan indications targeting inflammation, coagulopathies and disorders of the central nervous system, today announced recent highlights and developments as well as financial results for the first quarter of 2015, which include:

Successfully completed Omidria controlled launch followed by initiation of broad U.S. launch in first part of April Net loss of $18.7 million, or $0.51 per share, which included $2.8 million ($0.08 per... More